# Comparison of Intravitreal Ranibizumab and Macular Grid-pattern Laser for Treatment of Diabetic Macular Edema

> **NCT00994799** · — · UNKNOWN · sponsor: **Szeged University** · enrollment: 50 (estimated)

## Conditions studied

- Macular Edema

## Interventions

- **DRUG:** ranibizumab
- **RADIATION:** macular grid-pattern laser

## Key facts

- **NCT ID:** NCT00994799
- **Lead sponsor:** Szeged University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-07
- **Primary completion:** —
- **Final completion:** 2011-02
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2009-10-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00994799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00994799, "Comparison of Intravitreal Ranibizumab and Macular Grid-pattern Laser for Treatment of Diabetic Macular Edema". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00994799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*